{"id":11662,"date":"2023-03-27T06:29:35","date_gmt":"2023-03-27T04:29:35","guid":{"rendered":"https:\/\/ggba.swiss\/alithea-genomics-decroche-chf-500000-pour-developper-sa-technologie-de-sequencage-de-larn\/"},"modified":"2023-07-04T13:44:15","modified_gmt":"2023-07-04T11:44:15","slug":"alithea-genomics-decroche-chf-500000-pour-developper-sa-technologie-de-sequencage-de-larn","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/alithea-genomics-decroche-chf-500000-pour-developper-sa-technologie-de-sequencage-de-larn\/","title":{"rendered":"Alithea Genomics d\u00e9croche CHF 500&rsquo;000 pour d\u00e9velopper sa technologie de s\u00e9quen\u00e7age de l&rsquo;ARN"},"content":{"rendered":"\n<p><a href=\"https:\/\/alitheagenomics.com\/\" target=\"_blank\" rel=\"noopener\">Alithea Genomics<\/a>, une start-up lausannoise sp\u00e9cialis\u00e9e dans le s\u00e9quen\u00e7age de l&rsquo;ARN \u00e0 haut d\u00e9bit, a obtenu un pr\u00eat Tech Growth de CHF 500&rsquo;000 de la Fondation pour l&rsquo;innovation technologique (<a href=\"https:\/\/www.fondation-fit.ch\/fr\/\" target=\"_blank\" rel=\"noopener\">FIT<\/a>). Ce pr\u00eat servira \u00e0 soutenir le lancement de deux nouveaux produits et permettra \u00e0 Alithea de couvrir la p\u00e9riode entre les tours de financement d&rsquo;amor\u00e7age et de s\u00e9rie A.<\/p>\n<p>Le s\u00e9quen\u00e7age de l&rsquo;ARN est un outil pr\u00e9cieux pour la recherche biom\u00e9dicale, qui permet aux scientifiques d&rsquo;examiner l&rsquo;expression des g\u00e8nes, de d\u00e9couvrir de nouveaux biomarqueurs et de mettre au point de nouveaux m\u00e9dicaments. Cependant, le processus actuel est long, co\u00fbteux et laborieux, ce qui rend difficile l&rsquo;application du s\u00e9quen\u00e7age de l&rsquo;ARN \u00e0 des domaines plus translationnels, tels que la d\u00e9couverte de biomarqueurs et le d\u00e9veloppement de m\u00e9dicaments.<\/p>\n<p>Alithea Genomics vise \u00e0 relever ce d\u00e9fi gr\u00e2ce \u00e0 sa technologie propri\u00e9taire, le Bulk RNA Barcoding followed by sequencing (BRB-seq), qui permet de pr\u00e9parer des milliers d&rsquo;\u00e9chantillons d&rsquo;ARN pour le s\u00e9quen\u00e7age dans un seul tube. Contrairement \u00e0 la pr\u00e9paration standard des \u00e9chantillons d&rsquo;ARN-seq, qui implique une longue s\u00e9rie d&rsquo;op\u00e9rations manuelles et de r\u00e9actions enzymatiques, le BRB-seq consiste \u00e0 traiter les \u00e9chantillons individuellement uniquement au cours de la premi\u00e8re r\u00e9action du flux de travail. Apr\u00e8s cette \u00e9tape de \u00ab\u00a0marquage\u00a0\u00bb, tous les \u00e9chantillons peuvent \u00eatre regroup\u00e9s et trait\u00e9s dans un seul tube pour le reste du processus.<\/p>\n<p>Le r\u00e9sultat est un processus tr\u00e8s efficace et rentable qui fournit aux plateformes de R&amp;D des donn\u00e9es utilisables compl\u00e8tes et pertinentes, rendant plus efficaces les analyses de biobanques et les efforts de criblage de m\u00e9dicaments. Le champ des possibilit\u00e9s est infini et laisse entrevoir la possibilit\u00e9 de d\u00e9mocratiser ce processus \u00e0 l&rsquo;avenir.<\/p>\n<p>Depuis le lancement de son premier service en mai 2020 et du <a href=\"https:\/\/ggba.swiss\/fr\/specialiste-solutions-transcriptomiques-alithea-genomics-leve-chf-150000\/\" target=\"_blank\" rel=\"noopener\">premier kit en mai 2021<\/a>, Alithea a rapidement augment\u00e9 son portefeuille de produits pour inclure une large s\u00e9lection de 15 kits diff\u00e9rents et quatre types de services diff\u00e9rents. La client\u00e8le de la start-up est r\u00e9partie entre la Suisse, l&rsquo;Europe et l&rsquo;Am\u00e9rique du Nord.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Alithea Genomics a obtenu un pr\u00eat Tech Growth de CHF 500&rsquo;000 du FIT pour lancer deux nouveaux produits et \u00e9largir son portefeuille de technologies de s\u00e9quen\u00e7age de l&rsquo;ARN.<\/p>\n","protected":false},"author":3,"featured_media":11663,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1022,1032,1041,1065,1068],"class_list":["post-11662","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-biotech-fr","tag-diagnostic-fr","tag-financing-fr","tag-oncology-fr","tag-personalized-medicine-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Alithea Genomics d\u00e9croche CHF 500&#039;000 pour d\u00e9velopper sa technologie de s\u00e9quen\u00e7age de l&#039;ARN - Greater Geneva Bern area<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/alithea-genomics-decroche-chf-500000-pour-developper-sa-technologie-de-sequencage-de-larn\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alithea Genomics d\u00e9croche CHF 500&#039;000 pour d\u00e9velopper sa technologie de s\u00e9quen\u00e7age de l&#039;ARN - Greater Geneva Bern area\" \/>\n<meta property=\"og:description\" content=\"Alithea Genomics a obtenu un pr\u00eat Tech Growth de CHF 500&#039;000 du FIT pour lancer deux nouveaux produits et \u00e9largir son portefeuille de technologies de s\u00e9quen\u00e7age de l&#039;ARN.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/alithea-genomics-decroche-chf-500000-pour-developper-sa-technologie-de-sequencage-de-larn\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-27T04:29:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-04T11:44:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/Alithea-Genomics-630x380-1-2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"630\" \/>\n\t<meta property=\"og:image:height\" content=\"380\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"mathieu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"mathieu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/alithea-genomics-decroche-chf-500000-pour-developper-sa-technologie-de-sequencage-de-larn\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/alithea-genomics-decroche-chf-500000-pour-developper-sa-technologie-de-sequencage-de-larn\/\"},\"author\":{\"name\":\"mathieu\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"headline\":\"Alithea Genomics d\u00e9croche CHF 500&rsquo;000 pour d\u00e9velopper sa technologie de s\u00e9quen\u00e7age de l&rsquo;ARN\",\"datePublished\":\"2023-03-27T04:29:35+00:00\",\"dateModified\":\"2023-07-04T11:44:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/alithea-genomics-decroche-chf-500000-pour-developper-sa-technologie-de-sequencage-de-larn\/\"},\"wordCount\":400,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/alithea-genomics-decroche-chf-500000-pour-developper-sa-technologie-de-sequencage-de-larn\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Alithea-Genomics-630x380-1-2.jpg\",\"keywords\":[\"Biotech\",\"Diagnostic\",\"Financing\",\"Oncology\",\"Personalized Medicine\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/alithea-genomics-decroche-chf-500000-pour-developper-sa-technologie-de-sequencage-de-larn\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/alithea-genomics-decroche-chf-500000-pour-developper-sa-technologie-de-sequencage-de-larn\/\",\"name\":\"Alithea Genomics d\u00e9croche CHF 500'000 pour d\u00e9velopper sa technologie de s\u00e9quen\u00e7age de l'ARN - Greater Geneva Bern area\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/alithea-genomics-decroche-chf-500000-pour-developper-sa-technologie-de-sequencage-de-larn\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/alithea-genomics-decroche-chf-500000-pour-developper-sa-technologie-de-sequencage-de-larn\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Alithea-Genomics-630x380-1-2.jpg\",\"datePublished\":\"2023-03-27T04:29:35+00:00\",\"dateModified\":\"2023-07-04T11:44:15+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/alithea-genomics-decroche-chf-500000-pour-developper-sa-technologie-de-sequencage-de-larn\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/alithea-genomics-decroche-chf-500000-pour-developper-sa-technologie-de-sequencage-de-larn\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/alithea-genomics-decroche-chf-500000-pour-developper-sa-technologie-de-sequencage-de-larn\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Alithea-Genomics-630x380-1-2.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Alithea-Genomics-630x380-1-2.jpg\",\"width\":630,\"height\":380},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/alithea-genomics-decroche-chf-500000-pour-developper-sa-technologie-de-sequencage-de-larn\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alithea Genomics d\u00e9croche CHF 500&rsquo;000 pour d\u00e9velopper sa technologie de s\u00e9quen\u00e7age de l&rsquo;ARN\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\",\"name\":\"mathieu\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/mathieu\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alithea Genomics d\u00e9croche CHF 500'000 pour d\u00e9velopper sa technologie de s\u00e9quen\u00e7age de l'ARN - Greater Geneva Bern area","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/alithea-genomics-decroche-chf-500000-pour-developper-sa-technologie-de-sequencage-de-larn\/","og_locale":"fr_FR","og_type":"article","og_title":"Alithea Genomics d\u00e9croche CHF 500'000 pour d\u00e9velopper sa technologie de s\u00e9quen\u00e7age de l'ARN - Greater Geneva Bern area","og_description":"Alithea Genomics a obtenu un pr\u00eat Tech Growth de CHF 500'000 du FIT pour lancer deux nouveaux produits et \u00e9largir son portefeuille de technologies de s\u00e9quen\u00e7age de l'ARN.","og_url":"https:\/\/ggba.swiss\/fr\/alithea-genomics-decroche-chf-500000-pour-developper-sa-technologie-de-sequencage-de-larn\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2023-03-27T04:29:35+00:00","article_modified_time":"2023-07-04T11:44:15+00:00","og_image":[{"width":630,"height":380,"url":"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/Alithea-Genomics-630x380-1-2.jpg","type":"image\/jpeg"}],"author":"mathieu","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"mathieu","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/alithea-genomics-decroche-chf-500000-pour-developper-sa-technologie-de-sequencage-de-larn\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/alithea-genomics-decroche-chf-500000-pour-developper-sa-technologie-de-sequencage-de-larn\/"},"author":{"name":"mathieu","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"headline":"Alithea Genomics d\u00e9croche CHF 500&rsquo;000 pour d\u00e9velopper sa technologie de s\u00e9quen\u00e7age de l&rsquo;ARN","datePublished":"2023-03-27T04:29:35+00:00","dateModified":"2023-07-04T11:44:15+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/alithea-genomics-decroche-chf-500000-pour-developper-sa-technologie-de-sequencage-de-larn\/"},"wordCount":400,"image":{"@id":"https:\/\/ggba.swiss\/fr\/alithea-genomics-decroche-chf-500000-pour-developper-sa-technologie-de-sequencage-de-larn\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Alithea-Genomics-630x380-1-2.jpg","keywords":["Biotech","Diagnostic","Financing","Oncology","Personalized Medicine"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/alithea-genomics-decroche-chf-500000-pour-developper-sa-technologie-de-sequencage-de-larn\/","url":"https:\/\/ggba.swiss\/fr\/alithea-genomics-decroche-chf-500000-pour-developper-sa-technologie-de-sequencage-de-larn\/","name":"Alithea Genomics d\u00e9croche CHF 500'000 pour d\u00e9velopper sa technologie de s\u00e9quen\u00e7age de l'ARN - Greater Geneva Bern area","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/alithea-genomics-decroche-chf-500000-pour-developper-sa-technologie-de-sequencage-de-larn\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/alithea-genomics-decroche-chf-500000-pour-developper-sa-technologie-de-sequencage-de-larn\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Alithea-Genomics-630x380-1-2.jpg","datePublished":"2023-03-27T04:29:35+00:00","dateModified":"2023-07-04T11:44:15+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/alithea-genomics-decroche-chf-500000-pour-developper-sa-technologie-de-sequencage-de-larn\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/alithea-genomics-decroche-chf-500000-pour-developper-sa-technologie-de-sequencage-de-larn\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/alithea-genomics-decroche-chf-500000-pour-developper-sa-technologie-de-sequencage-de-larn\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Alithea-Genomics-630x380-1-2.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Alithea-Genomics-630x380-1-2.jpg","width":630,"height":380},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/alithea-genomics-decroche-chf-500000-pour-developper-sa-technologie-de-sequencage-de-larn\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"Alithea Genomics d\u00e9croche CHF 500&rsquo;000 pour d\u00e9velopper sa technologie de s\u00e9quen\u00e7age de l&rsquo;ARN"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab","name":"mathieu","url":"https:\/\/ggba.swiss\/fr\/author\/mathieu\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/11662","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=11662"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/11662\/revisions"}],"predecessor-version":[{"id":18340,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/11662\/revisions\/18340"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/11663"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=11662"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=11662"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=11662"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}